Pesonen, Ida http://orcid.org/0000-0001-8977-7462
Carlson, Lisa
Murgia, Nicola
Kaarteenaho, Riitta
Sköld, Carl Magnus
Myllärniemi, Marjukka
Ferrara, Giovanni
Article History
Received: 12 March 2018
Accepted: 5 April 2018
First Online: 14 May 2018
Ethics approval and consent to participate
: The study was performed under the approval of the Stockholm’s Regional Ethical Committee (Ref No. 2014/1202–31/4) for what concerns the Swedish Registry. The Finnish IPF registry and studies on the registry were approved by Helsinki University Hospital ethical committee concerning all five University Hospitals that form centers for healthcare units in Finland (Ref. No. HUS 426/13/03/01/09, HUS/2550/2017). The Finnish National Institute for Health and Welfare gave permission to screen for patients from hospital registries using ICD-10-codes (THL/1161/5.05.01/2012).Patients are asked to sign an informed consent upon inclusion.
: IP has received fees for lectures from Boehringer Ingelheim.LC has received fees for lectures from Boehringer Ingelheim and Roche.GF has received fees for lectures from Boehringer Ingelheim and Roche. In addition, he is Associate Editor of Multidisciplinary Respiratory Medicine.RK has received fees for lectures from GSK, Ratiopharm and Roche.NM has received travel grants from TEVA, Menarini and fees for lectures from AstraZeneca, Menarini and Chiesi Farmaceutici. Other authors have no competing interests to declare.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.